Johnson Pharmacare Ltd. to approve quarterly results at a board meeting on August 13 Back
Johnson Pharmacare Ltd. will hold a board meeting on Thursday, August 13, to approve the unaudited standalone financial results for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited. The company closed its trading window on July 1, 2026, and it will remain closed until 48 hours after the unaudited results are declared.